Highlights of the 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease

Highlights of the 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease

Download the highlights here.

The 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease represents a major revision and update to the 2006 and 2008 AHA/ACC guidelines. There are substantial changes in multiple areas including the characterisation of heart valve disease, how patients should be followed and referred for additional evaluation, thresholds for intervention, the types of available intervention, and post-intervention management. This document is an attempt to highlight a few areas that are anticipated to have a broad impact in patient management, but it is by no means exhaustive. Clinicians involved in the care of patients with heart valve disease are encouraged to read at least the executive summary, if not the entire 2014 AHA/ACC Guideline document, which is available online. David S. Bach, MD, F.A.C.C. (excerpt from the document)

 

The full guideline document is available here.

 

edwards-lifesciences

About The Author

Structural Heart Disease Australia

Structural Heart Disease Australia is an incorporated association focused on education in valvular and structural cardiac diseases. It was started by group of echocardiographers, anaesthetists, clinical and interventional cardiologists, and cardiothoracic surgeons to provide a useful learning resource for medical professionals.

SHDA is supported by

Recent Tweets

Subscribe

Upcoming Meetings

july

28julAll DaySHDA Aortic Valve Symposium 2018SHDA AVS 2018

august

02augAll Day05Cardiac Society of Australia & New Zealand (CSANZ) 66th Annual Scientific MeetingCSANZ 2018

03augAll Day05Australia & New Zealand Endovascular Therapies (ANZET) Meeting 2018ANZET 2018

25augAll Day29European Society of Cardiology (ESC) Congress 2018ESC 2018

X